Eli Lilly 2015 Annual Report Download - page 57

Download and view the complete annual report

Please find page 57 of the 2015 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 186

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186

F45
FINANCIAL REPORT
Financial Statements and Supplementary Data
Consolidated Statements of Operations
ELI LILLY AND COMPANY AND SUBSIDIARIES
(Dollars in millions and shares in thousands,
except per-share data) Year Ended December 31 2015 2014 2013
Revenue $ 19,958.7 $ 19,615.6 $ 23,113.1
Costs, expenses, and other:
Cost of sales 5,037.2 4,932.5 4,908.1
Research and development 4,796.4 4,733.6 5,531.3
Marketing, selling, and administrative 6,533.0 6,620.8 7,125.6
Acquired in-process research and development (Notes 3 and
4) 535.0 200.2 57.1
Asset impairment, restructuring, and other special charges
(Note 5) 367.7 468.7 120.6
Other—net, (income) expense (Note 17) (100.6) (340.5) (518.9)
17,168.7 16,615.3 17,223.8
Income before income taxes 2,790.0 3,000.3 5,889.3
Income taxes (Note 13) 381.6 609.8 1,204.5
Net income $ 2,408.4 $ 2,390.5 $ 4,684.8
Earnings per share:
Basic $ 2.27 $ 2.23 $ 4.33
Diluted 2.26 2.23 4.32
Shares used in calculation of earnings per share:
Basic 1,061,913 1,069,932 1,080,874
Diluted 1,065,720 1,074,286 1,084,766
See notes to consolidated financial statements.
Consolidated Statements of Operations